Tradestie Institutional Equity Comparison Engine

ALKS vs ARIA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ALKS Overall Edge

ALKS Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Alkermes Inc. plc (ALKS) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ALKS trades at 133.3x Forward P/E with 11.5% operating margin (+21.8% YoY revenue) versus ARIA at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, ALKS sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro) against ARIA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner ALKS
ALKS 133.3x vs ARIA N/M Fwd P/E
Growth & Margin Winner ALKS
Op Margin 11.5% vs N/A ยท YoY +21.8% vs N/A
Momentum & Technical Winner ALKS
1Y +50.0% vs -17.0% ยท 52W Pos 68% vs 0%
Options & Structure Winner ALKS
CONSOLIDATION (6th %ile IV) vs UNCLASSIFIED (N/A IV)
ALKS NASDAQ
Alkermes Inc. plc
Pharmaceutical Preparations
$46.53
-1.06% 1D
Market Cap $7.9B
1M Return +12.88%
1Y Return +50.05%
Forward P/E 133.3x
Unified AI Score
32.1 / 100 SELL
Tech 16.0 Fund 39.0 Flow 68.0 Mom 40.0
ARIA US Equity
ARIA
Institutional Equity
$21.03
-3.52% 1D
Market Cap N/A
1M Return -11.55%
1Y Return -16.97%
Forward P/E N/M
Unified AI Score
47.7 / 100 HOLD
Tech 50.0 Fund 52.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ALKS +50.05% ARIA -16.97% Spread: +11.16 pp (ALKS Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ALKS TTM Op. Margin: 11.5% ARIA TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ALKS vs ARIA. Trailing 12-month operating profitability (ALKS 11.5% vs ARIA N/A) and valuation multiples (ALKS 133.3x vs ARIA N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ALKS (9) vs ARIA (1)
Institutional Metric ALKS ARIA Criterion Row Winner
Market Capitalization Scale $7.9B N/A Larger Scale ALKS
Trailing P/E Ratio Valuation 133.3x N/M Lower Multiple ALKS
Forward P/E Ratio Valuation 133.3x N/M Lower Multiple ALKS
Revenue Growth (YoY) Growth +21.8% N/A Higher Growth ALKS
Operating Margin (TTM) Profitability 11.5% N/A Higher Margin ALKS
Net Profit Margin Profitability -0.0% N/A Higher Margin ALKS
Return on Equity (ROE) Capital Efficiency -0.0% N/A Higher ROE ALKS
52-Week Range Position Momentum 68% ($27โ€“$56) 0% ($21โ€“$27) Stronger Trend ALKS
Beta / 30D Volatility Risk Regime 0.75ฮฒ ยท 26% Vol 1.92ฮฒ ยท 43% Vol Lower Realized Risk ALKS
Unified Institutional Score Composite Signal 32.1 / 100 (SELL) 47.7 / 100 (HOLD) Higher Composite ARIA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ALKS vs ARIA Buy Guide
ALKS CONSOLIDATION
101d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live ALKS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ARIA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ARIA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ALKS nor ARIA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.